CBIO Return on Tangible Equity | CRESCENT BIOPHARMA, INC.

CRESCENT BIOPHARMA, INC. (CBIO) Return on Tangible Equity

2026-06-30: Return Tang Equity -58.82%.
2026-03-31: Return Tang Equity -50.57%.
2025-12-31: Return Tang Equity -41.79%.
2025-09-30: Return Tang Equity -58.96%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-58.82%
2026-03-31	-50.57%
2025-12-31	-41.79%
2025-09-30	-58.96%
2025-06-30	-38.77%
2025-03-31	140.22%
2024-12-31	244.71%
2024-09-30	3051.85%
2024-06-30	-194.96%
2024-03-31	-128.94%
2023-12-31	-96.06%
2023-09-30	-81.78%
2023-06-30	-68.22%
2023-03-31	-68.18%
2022-12-31	-108.76%
2022-09-30	-111.95%
2022-06-30	-112.47%
2022-03-31	-93.79%
2021-12-31	-77.73%
2021-09-30	-63.76%
2021-06-30	-51.62%
2021-03-31	-46.07%
2020-12-31	-39.80%
2020-09-30	-36.30%
2020-06-30	-34.11%
2020-03-31	-34.66%
2019-12-31	-37.54%
2019-09-30	-34.16%
2019-06-30	-31.02%
2019-03-31	-26.37%
2018-12-31	-23.38%
2018-09-30	-19.90%
2018-06-30	-17.44%
2018-03-31	-15.39%
2017-12-31	-27.80%
2017-09-30	-29.80%
2017-06-30	-27.94%
2017-03-31	-100.94%
2016-12-31	-90.11%
2016-09-30	-77.51%
2016-06-30	-64.81%
2016-03-31	-38.01%
2015-12-31	-31.55%
2015-09-30	-23.16%
2015-06-30	-19.43%
2015-03-31	-29.60%
2014-12-31	-21.89%
2014-09-30	-13.16%
2014-06-30	-7.32%
2014-03-31	-29.21%
2013-12-31	-364.78%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-75.83%
2024-12-31	244.71%
2023-12-31	-96.06%
2022-12-31	-108.76%
2021-12-31	-77.73%
2020-12-31	-39.80%
2019-12-31	-37.54%
2018-12-31	-23.49%
2017-12-31	-27.80%
2016-12-31	-90.11%
2015-12-31	-31.55%
2014-12-31	-21.89%
2013-12-31	-364.78%
2012-12-31	29.18%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
ARVINAS, INC. (ARVN)	United States	$0.510B	58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)	United States	$0.507B	15.53
CAPRICOR THERAPEUTICS, INC. (CAPR)	United States	$0.499B	-10.81
Ovid Therapeutics Inc. (OVID)	United States	$0.487B	-14.41
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
ASSEMBLY BIOSCIENCES, INC. (ASMB)	United States	$0.481B	-13,053.96
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82